Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06467487 · ClinicalTrials.gov registry record · NA
Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2
A NA study of Patient Participation, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 214,526
- Enrollment target
- 1
- Study location
NCT06467487: Completed NA study of Patient Participation, sponsored by Yale University.
NCT06467487 is a NA study of Patient Participation that has completed, run by Yale University. The registered enrollment target is 214,526 participants, above the 145,653-participant average among 5 other Patient Participation trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06467487, a NA study of Patient Participation, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 214,526 participants
- Enrollment target
- 1
- Study location
Study Summary
Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.
Primary Outcome
The outcome will be assessed by querying the patient's electronic medical record to determine whether the patient has registered in the Yale University Volunteer Database. This database is comprised of patients who agree to be contacted if there is a study at Yale that meets their interests.
Conditions Studied
Interventions
- OTHER Traditional Letter
- OTHER Direct to Patient Message
- OTHER Optimized Letter
- OTHER Direct to Patient Message - Optimized
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214,526 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2025-01-06 |
| Phase | NA |
What the finished NCT06467487 record still lists
NCT06467487 is an interventional study that assigns participants to a tested intervention. Its 214,526 participants enrollment target places it among the larger protocols in the corpus, above the 145,653-participant average among 5 other Patient Participation trials with a reported enrollment target (47% higher).
The record links to 1 condition, with Patient Participation appearing as the primary indexed condition, and to 4 interventions - of which Traditional Letter is the first listed.
NCT06467487 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06467487 about?
NCT06467487 is a clinical study titled "Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2". Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in ...
What is the current status of trial NCT06467487?
This trial is currently completed. It is a NA study. The enrollment target is 214,526 participants. The study started on 2024-09-04. Estimated completion is 2025-01-06.
What conditions does trial NCT06467487 study?
This clinical trial studies the following conditions: Patient Participation.
What interventions are being tested in trial NCT06467487?
The interventions under investigation include: Traditional Letter (OTHER), Direct to Patient Message (OTHER), Optimized Letter (OTHER), Direct to Patient Message - Optimized (OTHER).
Who is sponsoring clinical trial NCT06467487?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06467487 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Participation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clean Hands Accessible and Manageable for Patients (CHAMPs)
RECRUITING · NA
-
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
RECRUITING · NA
-
Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials
COMPLETED · NA
-
Priming and Patient Reported Outcome Measures
COMPLETED · NA
-
Electronic Health Record Strategies to Promote Diverse Participation in Research
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI